Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001;88:103-109

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinnaeve, P.
Right arrow Articles by Janssens, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinnaeve, P.
Right arrow Articles by Janssens, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Restenosis
Right arrow Gene expression
Right arrow Smooth muscle proliferation and differentiation
Right arrow Gene therapy
Right arrow Endothelium/vascular type/nitric oxide
(Circulation Research. 2001;88:103.)
© 2001 American Heart Association, Inc.


Integrative Physiology

Soluble Guanylate Cyclase {alpha}1 and ß1 Gene Transfer Increases NO Responsiveness and Reduces Neointima Formation After Balloon Injury in Rats via Antiproliferative and Antimigratory Effects

Peter Sinnaeve, Jean-Daniel Chiche, Zengxuang Nong, Olivier Varenne, Natascha Van Pelt, Hilde Gillijns, Desire Collen, Kenneth D. Bloch, Stefan Janssens

From the Center for Transgene Technology and Gene Therapy (P.S., Z.N., O.V., H.G., D.C., S.J.), Flanders Interuniversity Institute for Biotechnology, and the Cardiac Unit (P.S., N.V.P., S.J.), University Hospital Gasthuisberg, University of Leuven, Belgium, and Cardiovascular Research Center and Cardiology Division, Department of Medicine (J-D.C., K.D.B.), Massachusetts General Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Stefan Janssens, MD, PhD, Cardiac Unit and Center for Transgene Technology and Gene Therapy, KU-Leuven, Campus Gasthuisberg, Herestraat 49, B-3000, Leuven, Belgium. E-mail stefan.janssens{at}med.kuleuven.ac.be

Abstract—In vascular smooth muscle cells, NO stimulates the synthesis of cGMP by soluble guanylate cyclase (sGC), a heterodimer composed of {alpha}1 and ß1 subunits. NO/cGMP signal transduction affects multiple cell functions that contribute to neointima formation after vascular injury. Balloon-induced vascular injury was found to decrease sGC subunit expression and enzyme activity in rat carotid arteries. The effect of restoring sGC enzyme activity on neointima formation was investigated using recombinant adenoviruses specifying sGC {alpha}1 and ß1 subunits (Ad{alpha}1 and Adß1). Coinfection of cultured rat aortic smooth muscle cells with Ad{alpha}1 and Adß1 increased NO-stimulated intracellular cGMP levels 60-fold and decreased DNA synthesis and migration by 16% and 48%, respectively. Immunoreactivity for {alpha}1 and ß1 subunits colocalized in carotid arteries infected with Ad{alpha}1 and Adß1. Molsidomine-stimulated carotid tissue cGMP levels were greater after coinfection with Ad{alpha}1 and Adß1 than after infection with a control virus, AdRR5 (0.53±0.09 pmol/mg protein, mean±SEM, versus 0.23±0.09, P<0.05). Mean intima/media ratio, 2 weeks after balloon injury and twice-daily administration of 5 mg/kg molsidomine, was less in rats coinfected with Ad{alpha}1 and Adß1 than in rats infected with AdRR5 or in uninfected rats (0.36±0.11 versus 0.81±0.13 and 0.75±0.25, respectively, P<0.05). Thus, Ad{alpha}1 and Adß1 gene transfer to balloon-injured rat carotid arteries increases NO responsiveness and attenuates neointima formation via a direct antiproliferative and antimigratory effect on vascular smooth muscle cells.


Key Words: cyclic GMP • soluble guanylate cyclase • nitric oxide • adenovirus • gene therapy




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Hirschberg, T. Radovits, S. Loganathan, L. Entz, C. J. Beller, M.-L. Gross, P. Sandner, M. Karck, and G. Szabo
Selective phosphodiesterase-5 inhibition reduces neointimal hyperplasia in rat carotid arteries after surgical endarterectomy.
J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1508 - 1514.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Lukowski, P. Weinmeister, D. Bernhard, S. Feil, M. Gotthardt, J. Herz, S. Massberg, A. Zernecke, C. Weber, F. Hofmann, et al.
Role of Smooth Muscle cGMP/cGKI Signaling in Murine Vascular Restenosis
Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1244 - 1250.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Zhang, S. Zhuang, D. E. Casteel, D. J. Looney, G. R. Boss, and R. B. Pilz
A Cysteine-rich LIM-only Protein Mediates Regulation of Smooth Muscle-specific Gene Expression by cGMP-dependent Protein Kinase
J. Biol. Chem., November 16, 2007; 282(46): 33367 - 33380.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Vermeersch, E. Buys, P. Pokreisz, G. Marsboom, F. Ichinose, P. Sips, M. Pellens, H. Gillijns, M. Swinnen, A. Graveline, et al.
Soluble Guanylate Cyclase-{alpha}1 Deficiency Selectively Inhibits the Pulmonary Vasodilator Response to Nitric Oxide and Increases the Pulmonary Vascular Remodeling Response to Chronic Hypoxia
Circulation, August 21, 2007; 116(8): 936 - 943.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. Pacher, J. S. Beckman, and L. Liaudet
Nitric Oxide and Peroxynitrite in Health and Disease
Physiol Rev, January 1, 2007; 87(1): 315 - 424.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Agullo, D. Garcia-Dorado, N. Escalona, M. Ruiz-Meana, M. Mirabet, J. Inserte, and J. Soler-Soler
Membrane association of nitric oxide-sensitive guanylyl cyclase in cardiomyocytes
Cardiovasc Res, October 1, 2005; 68(1): 65 - 74.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Kloss, D. Rodenbach, R. Bordel, and A. Mulsch
Human-Antigen R (HuR) Expression in Hypertension: Downregulation of the mRNA Stabilizing Protein HuR in Genetic Hypertension
Hypertension, June 1, 2005; 45(6): 1200 - 1206.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. C. Browner, N. B. Dey, K. D. Bloch, and T. M. Lincoln
Regulation of cGMP-dependent Protein Kinase Expression by Soluble Guanylyl Cyclase in Vascular Smooth Muscle Cells
J. Biol. Chem., November 5, 2004; 279(45): 46631 - 46636.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. B. Pilz and D. E. Casteel
Regulation of Gene Expression by Cyclic GMP
Circ. Res., November 28, 2003; 93(11): 1034 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Toda and T. Okamura
The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels
Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Sinnaeve, J.-D. Chiche, H. Gillijns, N. Van Pelt, D. Wirthlin, F. Van de Werf, D. Collen, K. D. Bloch, and S. Janssens
Overexpression of a Constitutively Active Protein Kinase G Mutant Reduces Neointima Formation and In-Stent Restenosis
Circulation, June 18, 2002; 105(24): 2911 - 2916.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Vermeersch, Z. Nong, E. Stabile, O. Varenne, H. Gillijns, M. Pellens, N. Van Pelt, M. Hoylaerts, I. De Scheerder, D. Collen, et al.
L-Arginine Administration Reduces Neointima Formation After Stent Injury in Rats by a Nitric Oxide-Mediated Mechanism
Arterioscler Thromb Vasc Biol, October 1, 2001; 21(10): 1604 - 1609.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
U. Laber, T. Kober, V. Schmitz, A. Schrammel, W. Meyer, B. Mayer, M. Weber, and G. Kojda
Effect of Hypercholesterolemia on Expression and Function of Vascular Soluble Guanylyl Cyclase
Circulation, February 19, 2002; 105(7): 855 - 860.
[Abstract] [Full Text] [PDF]